Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study.

MLA

Long, Michelle T., et al. “Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study.” Hepatology (Baltimore, Md.), vol. 73, no. 2, Feb. 2021, pp. 548–59. EBSCOhost, https://doi.org/10.1002/hep.31608.

APA

Long, M. T., Zhang, X., Xu, H., Liu, C.-T., Corey, K. E., Chung, R. T., Loomba, R., & Benjamin, E. J. (2021). Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study. Hepatology (Baltimore, Md.), 73(2), 548–559. https://doi.org/10.1002/hep.31608

Chicago

Long, Michelle T, Xiaoyu Zhang, Hanfei Xu, Ching-Ti Liu, Kathleen E Corey, Raymond T Chung, Rohit Loomba, and Emelia J Benjamin. 2021. “Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study.” Hepatology (Baltimore, Md.) 73 (2): 548–59. doi:10.1002/hep.31608.